Ergebnis der Suchanfrage nach M&uuml

Schweizerischer Nationalfonds / Fonds national suisse

Stacking - a route to higher-performance solid-state batteries

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex: Labor shortage impacts staffing service providers

50 Best

THE WORLD'S 50 BEST HOTELS REVEALS SPECIAL AWARDS CATEGORIES

London (ots/PRNewswire) - The World's 50 Best Hotels, the 50 Best brand's first global launch since 2009, announces the special awards which will complement the upcoming ranking Alongside the inaugural list of The World's 50 Best Hotels, which will be announced at a ceremony at the Guildhall, London on 19 September, 50 Best will reveal the winners of a series of award categories designed to highlight outstanding ...

SwissFinTechLadies

Injecting Organizational Efficiency with AI Chatbots: Entering a new era of organizational transformation and productivity

swissstaffing - Verband der Personaldienstleister der Schweiz

The labor market: Temporary work helps integrate the unemployed into the labor market and provides social security for flexible workers

COP28 UAE

COP28 President-Designate calls for climate finance reform to unlock Africa's clean energy potential

Nairobi, Kenya (ots/PRNewswire) - - Dr. Sultan Al Jaber, COP28 President-Designate, meets with H.E. William Ruto, President of the Republic of Kenya, and African energy ministers and leaders at Africa Energy Forum in Nairobi. - President Ruto commends UAE, its leadership and the COP Presidency on its long-standing ...

Akkodis

Akkodis Named 'Market Leader' Among Digital Engineering Service Providers in 2023 HFS Horizons Report

Zurich (ots/PRNewswire) - The leading global analyst firm's report recognizes that Akkodis 'embraces a digital-first mindset, driving digital transformation, human-in-context, design-led, ultra-agile approach.' Akkodis, a global digital engineering company, is delighted to announce that it has been named a 'Market ...

Debiopharm International SA

DEBIOPHARM SHARES ONCOLOGY PROGRAM UPDATES AT ASCO 2023 FOR NOVEL WEE1 INHIBITOR, AND FIRST-IN-CLASS CA IX THERANOSTIC APPROACH

Lausanne, Switzerland (ots) - - Debiopharm will highlight diversified approaches and commitment to improving outcomes for patients with cancer at the 2023 American Society of Clinical Oncology Conference - A poster presentation and discussion will cover promising interim results with Debio 0123, a potent, highly ...

Debiopharm International SA

DEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER

Lausanne, Switzerland (ots) - - Debiopharm combines its potent WEE1-inhibitor Debio 0123 with standard-of-care therapy to short-circuit DNA damage repair (DDR) in adults with recurrent or progressive small cell lung cancer (SCLC). - The first patient dosed at Vall d’Hebron Hospital (Barcelona, Spain), was ...

Grünenthal Group

Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee

Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...

Norgine B.V.

European study highlights need to improve the quality of conversations about induction of labour (IoL) in clinical settings

Amsterdam (ots/PRNewswire) - - Almost 1 in 2 women (49%) felt the experience of IoL differed from their expectations - The majority of expectant mothers (65%) did not feel fully involved in choosing which method of IoL they prefer - Findings emphasize the importance of collaborative decision-making between ...

Debiopharm International SA

DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS

Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...

Akkodis

Akkodis - Development partner for BMW i Vision Dee concept car

Zurich (ots/PRNewswire) - As an integral part of the development of the drivable concept car, Akkodis, a global leader in the Smart Industry, contributed its technical and digital expertise to the BMW i Vision Dee. Akkodis, part of the Adecco Group, has joined forces with the BMW Group to develop and produce the BMW i Vision Dee. Earlier this year, the BMW Group unveiled the BMW i Vision Dee to a global audience during ...

Aurisco

Aurisco Expands Oligonucleotide Capacity and Launches New Website

SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...

ARt+ Magazine

6

Art and Technology in Harmony: Michaela Litzka shows innovative augmented reality artworks in New York

ARt+ Magazine

6

Art and Technology in Harmony: Michaela Litzka shows innovative augmented reality artworks in New York

Euro Airport Basel-Mulhouse-Freiburg

Annual Report 2022: a return to a stable financial position

Aurisco

Aurisco Expands Oligonucleotide Capacity and Launches New Website

SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000TM solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...

Schweizerischer Nationalfonds / Fonds national suisse

Traffic noise - the enemy of our brains

Schweizerischer Nationalfonds / Fonds national suisse

Mummies provide the key to reconstruct the climate of the ancient Mediterranean

Bern (ots) - Swiss scientists are reconstructing the climate of the ancient world using small wooden artefacts hung on mummified remains. Throughout history, the earth's climate has undergone natural fluctuations. Although insignificant compared with the current crisis, these fluctuations would nevertheless have been enough to make and unmake empires. According to ...

Eurelectric

Reaching net-zero: Eurelectric's three pillars for Europe's electricity market reform

Brussels (ots/PRNewswire) - Today, the European Electricity trade association Eurelectric releases its landmark study on how to make the EU electricity market design fit for a net-zero future. The conclusion is clear: Europe's power market needs an evolution that builds on the existing structure which has been refined over more than two decades. The study proposes to ...

Debiopharm International SA

Iktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and solutions

Paris, France and Lausanne Switzerland (ots) - ● The round is co-led by M Ventures and Debiopharm Innovation Fund with Omnes Capital; all joining as new investors ● Series A will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service ...

BMO Financial Group

BMO Financial Group Reports First Quarter 2023 Results

Toronto (ots/PRNewswire) - BMO's First Quarter 2023 Report to Shareholders, including the unaudited interim consolidated financial statements for the period ended January 31, 2023, is available online at www.bmo.com/investorrelations and at www.sedar.com. Financial Results Highlights First Quarter 2023 Compared with First Quarter 2022: - Net income of $247 million, compared with $2,933 million; adjusted net income1,3 of ...

Schweizerischer Nationalfonds / Fonds national suisse

Brain scans of people with MS help us understand the effects of Covid

Bern (ots) - People affected by multiple sclerosis need to undergo regular MRI brain scans. The images are now being used to visualise the effects of a coronavirus infection. Brain fog, memory problems, loss of the sense of smell - Covid-19 affects the brain in a number of ways, yet the mechanisms behind this remain largely unknown. This is because disease-related changes in our brains are almost impossible to detect if ...